title: Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study.
abstract: BACKGROUND
  Antipsychotic drugs are limited in their ability to improve the overall outcome of schizophrenia. Adding psychosocial treatment may produce greater improvement in functional outcome than does medication treatment alone.
  
  
  OBJECTIVE
  To evaluate the effectiveness of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia.
  
  
  METHODS
  Randomized controlled trial.
  
  
  METHODS
  Ten clinical sites in China.
  
  
  METHODS
  Clinical sample of 1268 patients with early-stage schizophrenia treated from January 1, 2005, through October 31, 2007. Intervention Patients were randomly assigned to receive antipsychotic medication treatment only or antipsychotic medication plus 12 months of psychosocial intervention consisting of psychoeducation, family intervention, skills training, and cognitive behavior therapy administered during 48 group sessions.
  
  
  METHODS
  The rate of treatment discontinuation or change due to any cause, relapse or remission, and assessments of insight, treatment adherence, quality of life, and social functioning.
  
  
  RESULTS
  The rates of treatment discontinuation or change due to any cause were 32.8% in the combined treatment group and 46.8% in the medication-alone group. Comparisons with medication treatment alone showed lower risk of any-cause discontinuation with combined treatment (hazard ratio, 0.62; 95% confidence interval, 0.52-0.74; P < .001) and lower risk of relapse with combined treatment (0.57; 0.44-0.74; P < .001). The combined treatment group exhibited greater improvement in insight (P < .001), social functioning (P = .002), activities of daily living (P < .001), and 4 domains of quality of life as measured by the Medical Outcomes Study 36-Item Short Form Health Survey (all P < or = .02). Furthermore, a significantly higher proportion of patients receiving combined treatment obtained employment or accessed education (P = .001).
  
  
  CONCLUSIONS
  Compared with those receiving medication only, patients with early-stage schizophrenia receiving medication and psychosocial intervention have a lower rate of treatment discontinuation or change, a lower risk of relapse, and improved insight, quality of life, and social functioning.
  
  
  BACKGROUND
  clinicaltrials.gov Identifier: NCT00654576.
authors.affiliation: Mental Health Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
authors.forename: Xiaofeng
authors.initials: X
authors.lastname: Guo
authors.forename: Jinguo
authors.initials: J
authors.lastname: Zhai
authors.forename: Zhening
authors.initials: Z
authors.lastname: Liu
authors.forename: Maosheng
authors.initials: M
authors.lastname: Fang
authors.forename: Bo
authors.initials: B
authors.lastname: Wang
authors.forename: Chuanyue
authors.initials: C
authors.lastname: Wang
authors.forename: Bin
authors.initials: B
authors.lastname: Hu
authors.forename: Xueli
authors.initials: X
authors.lastname: Sun
authors.forename: Luxian
authors.initials: L
authors.lastname: Lv
authors.forename: Zheng
authors.initials: Z
authors.lastname: Lu
authors.forename: Cui
authors.initials: C
authors.lastname: Ma
authors.forename: Xiaolin
authors.initials: X
authors.lastname: He
authors.forename: Tiansheng
authors.initials: T
authors.lastname: Guo
authors.forename: Shiping
authors.initials: S
authors.lastname: Xie
authors.forename: Renrong
authors.initials: R
authors.lastname: Wu
authors.forename: Zhimin
authors.initials: Z
authors.lastname: Xue
authors.forename: Jindong
authors.initials: J
authors.lastname: Chen
authors.forename: Elizabeth W
authors.initials: EW
authors.lastname: Twamley
authors.forename: Hua
authors.initials: H
authors.lastname: Jin
authors.forename: Jingping
authors.initials: J
authors.lastname: Zhao
mesh_terms: D000203:Activities of Daily Living; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001294:Attitude to Health; D001364:Awareness; D002681:China; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D005260:Female; D006304:Health Status; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D010353:Patient Education as Topic; D011788:Quality of Life; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy*; D012917:Social Adjustment; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents
references.citation: N Engl J Med. 2005 Sep 22;353(12):1209-23
references.pmid: 16172203
references.citation: Br J Psychiatry Suppl. 2005 Aug;48:s85-90
references.pmid: 16055815
references.citation: Am J Psychiatry. 1996 Dec;153(12):1585-92
references.pmid: 8942455
references.citation: Gerontologist. 1969 Autumn;9(3):179-86
references.pmid: 5349366
references.citation: Am J Psychiatry. 2006 Mar;163(3):365-73
references.pmid: 16513854
references.citation: Schizophr Bull. 1987;13(2):261-76
references.pmid: 3616518
references.citation: J Nerv Ment Dis. 1989 Jan;177(1):43-7
references.pmid: 2562850
references.citation: Med Care. 1999 Jul;37(7):678-91
references.pmid: 10424639
references.citation: J Clin Psychiatry. 2006 Mar;67(3):453-60
references.pmid: 16649833
references.citation: Br J Psychiatry Suppl. 2005 Aug;48:s98-103
references.pmid: 16055817
references.citation: Br J Psychiatry Suppl. 2002 Sep;43:s91-7
references.pmid: 12271807
references.citation: N Engl J Med. 2002 Jan 3;346(1):16-22
references.pmid: 11777998
references.citation: Schizophr Bull. 2004;30(2):193-217
references.pmid: 15279040
references.citation: J Clin Psychiatry. 2007 May;68(5):730-7
references.pmid: 17503982
references.citation: Arch Gen Psychiatry. 2008 Jul;65(7):762-71
references.pmid: 18606949
references.citation: Psychiatr Serv. 2004 Aug;55(8):886-91
references.pmid: 15292538
references.citation: JAMA. 1963 Sep 21;185:914-9
references.pmid: 14044222
references.citation: Br J Psychiatry Suppl. 1998;172(33):53-9
references.pmid: 9764127
references.citation: Lancet. 2008 Mar 29;371(9618):1085-97
references.pmid: 18374841
references.citation: J Clin Psychiatry. 2004 Apr;65(4):531-6
references.pmid: 15119916
references.citation: Br J Psychiatry. 2004 Mar;184:231-9
references.pmid: 14990521
references.citation: Psychiatry Clin Neurosci. 1998 Dec;52 Suppl:S344-7
references.pmid: 9895189
references.citation: N Engl J Med. 2003 Oct 30;349(18):1738-49
references.pmid: 14585943
references.citation: Br J Psychiatry. 2005 May;186:394-9
references.pmid: 15863743
references.citation: Am J Psychiatry. 2005 Dec;162(12):2220-32
references.pmid: 16330584
references.citation: Br J Psychiatry. 1998 Jan;172:7-10
references.pmid: 9534824
references.citation: Acta Psychiatr Scand. 2006 Nov;114(5):328-36
references.pmid: 17022792
references.citation: Arch Gen Psychiatry. 1976 Jun;33(6):766-71
references.pmid: 938196
references.citation: Ann Neurol. 1990 Apr;27(4):428-37
references.pmid: 2353798
references.citation: Schizophr Bull. 2003;29(3):519-30
references.pmid: 14609245
references.citation: BMJ. 2005 Sep 17;331(7517):602
references.pmid: 16141449
references.citation: Med Care. 1992 Jun;30(6):473-83
references.pmid: 1593914
references.citation: Am J Psychiatry. 2004 Feb;161(2 Suppl):1-56
references.pmid: 15000267
references.citation: Br J Psychiatry. 2006 Jan;188:37-45
references.pmid: 16388068
references.citation: BMJ. 2004 Nov 6;329(7474):1067
references.pmid: 15485934
references.citation: J Psychiatr Ment Health Nurs. 2007 Jun;14(4):356-65
references.pmid: 17517026
references.citation: N Engl J Med. 2005 Aug 4;353(5):487-97
references.pmid: 16079372
references.citation: Schizophr Bull. 2006 Oct;32 Suppl 1:S1-9
references.pmid: 16920788
references.citation: Schizophr Res. 2008 Jan;98(1-3):1-7
references.pmid: 17936590
references.citation: Psychiatr Serv. 2001 Jan;52(1):31-3
references.pmid: 11141525